Adrienne Monson – Lifestyle
Author:
NetraMark Holdings Inc.
NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI
May 4, 2026
NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026
April 30, 2026
NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset
March 25, 2026
NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference
March 19, 2026
NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data
March 11, 2026